Authors: Basra, SK Drew, MGB Mann, J Kane, PD

Citation: Sk. Basra et al., A novel approach to bis-isoxazolines using a latent form of cyclopentadienone, J CHEM S P1, (21), 2000, pp. 3592-3598

Authors: Baettig, U Brown, L Brundish, D Dell, C Furzer, A Garman, S Janus, D Kane, PD Smith, G Walker, CV Cockcroft, XL Ambler, J Mitchelson, A Talbot, MD Tweed, M Wills, N

Citation: U. Baettig et al., The design and synthesis of thrombin inhibitors: Analogues of MD805 containing non-polar surrogates for arginine at the P1 position, BIOORG MED, 10(14), 2000, pp. 1563-1566

Authors: Hayler, J Kane, PD LeGrand, D Lugrin, F Menear, K Price, R Allen, M Cockcroft, XL Ambler, J Butler, K Dunnet, K Mitchelson, A Talbot, M Tweed, M Wills, N

Citation: J. Hayler et al., The design and synthesis of thrombin inhibitors: The introduction of in vivo efficacy and oral bioavailability into benzthiazolylalanine inhibitors, BIOORG MED, 10(14), 2000, pp. 1567-1570

Authors: Brundish, D Bull, A Donovan, V Fullerton, JD German, SM Hayler, JF Janus, D Kane, PD McDonnell, M Smith, GP Wakeford, R Walker, CV Howarth, G Hoyle, W Allen, MC Ambler, J Butler, K Talbot, MD

Citation: D. Brundish et al., Design and synthesis of thrombin inhibitors: Analogues of MD-805 with reduced stereogenicity and improved potency, J MED CHEM, 42(22), 1999, pp. 4584-4603